AngioDynamics
ANGO
149 hedge funds and large institutions have $474M invested in AngioDynamics in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 71 increasing their positions, 32 reducing their positions, and 21 closing their positions.
600% more call options, than puts
Call options by funds: $7K | Put options by funds: $1K
122% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 32
5% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 21
0% more funds holding
Funds holding: 149 → 149 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.35% less ownership
Funds ownership: 95.35% → 95% (-0.35%)
34% less capital invested
Capital invested by funds: $721M → $474M (-$247M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$19M |
| 2 |
Millennium Management
New York
|
+$14.9M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$11.5M |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.01M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$5.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.4M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$28.4M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14.3M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.2M |
| 5 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
-$4.24M |
ANGO Hedge Fund Activity: Q4 2022 in Review
149 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2022, worth a combined $474M — down 34% from $721M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new ANGO positions and 21 closed out — a net gain of 1 holder — while 71 added to existing stakes and 32 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $19M. The largest seller was Fidelity Investments, cutting an estimated $37.4M.
- 149 institutional investors held AngioDynamics (ANGO) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $474M of AngioDynamics stock for Q4 2022, down 34% quarter-over-quarter.
- 22 funds opened new AngioDynamics positions in Q4 2022 and 21 closed out, a net change of +1 holder.
- The largest AngioDynamics buyer in Q4 2022 was Victory Capital Management, an estimated $19M added.
- The largest AngioDynamics seller in Q4 2022 was Fidelity Investments, an estimated $37.4M sold.
Based on aggregated 13F filings for Q4 2022.